
201 - 500 employees
Founded 2003
🏥 Healthcare
💼 Consulting
📣 Marketing
🔥 Funding within the last year
💰 $500M Post-IPO Equity - Summit Therapeutics on 2025-10
Healthcare • Consulting • Marketing
Summit Therapeutics, Inc. is a biopharmaceutical oncology company focused on the discovery, development, and commercialization of novel medicinal therapies to improve quality and duration of life for patients with serious unmet medical needs. The company is advancing ivonescimab (SMT112), a novel bispecific antibody targeting PD-1 and VEGF, through multiple Phase 3 clinical trials for non-small cell lung cancer and other solid tumors under license from Akeso. Summit emphasizes clinical development, regulatory filing strategies, and potential commercialization in its licensed territories while promoting patient- and caregiver-friendly treatment options.
🔥 0 minutes ago
Improve your chances of getting an interview by checking your resume score before you apply.

201 - 500 employees
Founded 2003
🏥 Healthcare
💼 Consulting
📣 Marketing
🔥 Funding within the last year
💰 $500M Post-IPO Equity - Summit Therapeutics on 2025-10
Healthcare • Consulting • Marketing
Summit Therapeutics, Inc. is a biopharmaceutical oncology company focused on the discovery, development, and commercialization of novel medicinal therapies to improve quality and duration of life for patients with serious unmet medical needs. The company is advancing ivonescimab (SMT112), a novel bispecific antibody targeting PD-1 and VEGF, through multiple Phase 3 clinical trials for non-small cell lung cancer and other solid tumors under license from Akeso. Summit emphasizes clinical development, regulatory filing strategies, and potential commercialization in its licensed territories while promoting patient- and caregiver-friendly treatment options.
• Translate national brand and access strategies into actionable engagement plans across IDNs, Academic Centers, regional health systems, and select parent accounts of community provider networks • Lead account strategy and execution to accelerate clinical pathway and treatment protocol inclusion post-launch • Establish and maintain business-to-business and C-suite relationships with aligned key accounts • Build and sustain relationships with healthcare decision-makers across key oncology accounts • Collaborate cross-functionally with Commercial field teams to identify and resolve access or reimbursement barriers • Track and analyze business opportunities and market dynamics to inform access and commercial strategy • Negotiate contracts and agreements aligned with enterprise objectives and market access strategy • Share customer insights with brand teams, field leadership, and market access stakeholders • Manage relationships and identify opportunities with select access stakeholders • Provide strategic feedback to Commercial leadership regarding market dynamics, pathway decisions, and account priorities • Develop strategic engagement plans supporting multiple product and indication launches • Facilitate executive exchanges between Summit leadership and senior account executives • Communicate emerging opportunities or risks and mobilize internal resources • Design and lead pull-through initiatives with field commercial teams • Conduct quarterly business reviews with key accounts and internal stakeholders • Perform all other duties as assigned
• Bachelor’s degree required • Minimum of 10+ years of progressive experience in strategic account management, market access, or oncology commercial roles • Oncology experience required • Deep expertise and strong, established relationships across IDNs, Academic Centers, regional health systems, and community oncology accounts • Understanding of oncology reimbursement, economic flows, and market dynamics within IDNs, Academic Centers, GPOs, and community oncology environments • Exceptional communication and influencing skills to engage internal leadership and external executive stakeholders • Ability to communicate the value proposition of innovative oncology therapies • Strong negotiation skills with a track record of achieving outcomes aligned with enterprise and P&L objectives • Experience supporting pipeline products and oncology product launches • Ability to partner across Medical Affairs, Sales, Marketing, and Field Reimbursement teams • Willingness to travel up to 50% for customer meetings, industry conferences, and internal meetings • Preferred: advanced degree (MBA, Master’s, PharmD, or PhD) • Preferred: expertise in community oncology GPOs and oncology provider networks • Preferred: success leading strategic partnerships and executive engagement initiatives beyond traditional contracting or rebate arrangements • Preferred: oncology product launch experience within NSCLC • Preferred: prior people leadership experience and ability to help scale teams
• Potential bonus • Stock • Benefits • Other applicable variable compensation
Apply Now🔥 2 hours ago
Director expanding DMA’s corporate tax consulting market share across Northeast US. Managing strategic accounts, pursuing new business, and leading Practice Development growth initiatives.
🔥 2 hours ago
Pfizer Oncology medical director advancing payer and specialty-pharmacy outcomes through evidence, analytics, and medical strategy. Developing HIT solutions, customer partnerships, and research initiatives to improve patient care.
🇺🇸 United States – Remote
💵 $176.6k - $294.3k / year
💰 Post-IPO Debt on 2023-05
⏰ Full Time
🔴 Lead
👔 Director
🦅 H1B Visa Sponsor
🔥 2 hours ago
GoHealth urgent care Director leading enterprise data governance, BI, analytics, and AI-ready data foundations. Building high-performing teams and a multi-year data strategy across healthcare operations.
🔥 2 hours ago
Regional Business Director overseeing ClearChoice’s dental implant centers across Oregon and Washington. Driving multi-site operations, financial performance, growth, and patient satisfaction.
🔥 2 hours ago
Medical Affairs training director developing scientific resources and training for Novo Nordisk’s diabetes and obesity programs. Supporting field medical teams, launches, clinical updates and healthcare engagement.